Jon is the CEO of Lumanity, an Arsenal Capital-backed company focused on improving patient health by accelerating and optimizing access to effective medical advances. Jon brings 20+ years’ life sciences services experience. Previously he was the Founder and CEO of Evidera, a preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. Jon founded, grew and ultimately sold Evidera to PPD, where he was a member of the executive team for two years. Prior to Evidera, Jon was a Senior Vice President at Medco Health Solutions, and before that he was a Senior Principal with the Boston Consulting Group. Jon holds an MBA from the UCLA Anderson School of Management, where he was awarded the Dean’s Scholarship and Stephen J. Welsh and MDE Fellowships. He earned his undergraduate degrees in molecular biology and Japanese with high honors from Brigham Young. Jon currently serves on the Board of Directors of Hopebridge.